- Abridge and Kaiser Permanente debut Care Signals
- Built to Serve: The Day That Reminds Us Why We Chose Dentistry
- Journalists Catch You Up on Fauci Hearing, Peptides, and Kids’ Caffeine Consumption
- CMS finalizes 2.3% hospital pay bump, mandatory joint replacement model: 9 things to know
- How ambulatory shifts are reshaping perioperative strategy
- Cyclosporiasis cases top 18,000: 3 updates
- How Allegheny Health Network Strengthened its Foundation for IV Compounding Safety with Automation and Standardization¹
- Health plan customer service reps have AI in their ear
- Centene’s buyouts could have a $315M+ price tag for the rest of the year
- Medicare pay cut sparks specialty battle over skin cancer care
- Cardiovascular Institute of New England provides notice of data incident
- CMS locks in 2.3% inpatient hospital base pay increase, nudges back CJR-X Model start date
- Why autonomy — not just capital — is winning over cardiologists
- The $36 vs. $95 problem: How RVU negotiations are skewing physician pay
- Mississippi hospital board member, former CEO remembered as advocate for rural communities
- Pennsylvania SUD treatment locator reaches 146K users
- Top 10 dental, DSO stories in July
- Ohio youth treatment facility faces scrutiny over reported abuse: 8 notes
- What dental leaders told us in July
- Urban hospital closures and net change, by state
- ADSO sues Colorado Dental Board over practice ownership rule
- New patient acquisition is the top growth driver for dental practices: Report
- 20 new behavioral health projects to know
- Nurses, patients protest North Star Health Alliance ASC closure
- No Surprises Act under attack by payers: 8 things to know
- Dental staffing wages up 23% since 2021: ADA
- AtlantiCare appoints anesthesiology, gastroenterology physician leaders
- Consumer dental spending up 24% over 10 years: 5 stats to know
- Baylor Scott & White joint venture expands outpatient behavioral health services
- 5 DSOs making headlines
- VA to explore GLP-1 treatment for alcohol use disorder: 4 notes
- A $5B wave of M&A hits the ASC industry
- FTC Sues Hims & Hers Over Health Privacy And Billing Practices
- 145 physician medical groups led all healthcare M&A sectors in Q1
- 10 new ASCs in July
- Healthcare exec, telemedicine company owner sentenced for $35M DME fraud scheme
- Amylyx demystifies post-bariatric hypoglycemia with patient education website
- What Dad Eats Before Conception May Influence Baby's Health
- Family History Plays Role In Genetic Risk For Breast Cancer, Researchers Find
- A look at employers' attitudes toward ICHRAs
- Revised 340B Rebate Model Pilot Program moves forward, despite provider pushback
- Function Health lands $450M in growth financing to scale tech-enabled preventive health
- Daiichi Sankyo flags accounting error, as shares tank despite revenue beat
- AbbVie's Skyrizi shrugs off new competition as it thrives in growing psoriasis market
- Op-ed: Hospitals on the edge, a time for CMS to do no harm
- Daily Routine Key To Good Health, Study Says
- Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook
- Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis
- Psilocybin Therapy Helps Ease Veterans' Severe PTSD, Pilot Study Finds
- Newsom Reverses On Long-Sought Paid Leave Benefit For California Teachers
- Nicotine Levels Are Rising Among Teens Who Vape, New Study Warns
- The Newest Federally Recognized Tribe Wants Better Healthcare. It May Be On Its Own.
- They Worked To Protect Public Health. Now They Want the Public’s Votes.
- 27 new behavioral health study findings to know
- 21 state behavioral health policy updates
- What will fuel the next wave of DSO growth
- Dentists’ biggest staffing headaches
- Shionogi makes the call on COVID pill Xocova TV spot
- Psilocybin-assisted therapy reduced PTSD symptoms: 3 notes
- Fierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod
- Psychedelics, peptides and GLP-1s
- How 'physician-led' care team models tackle primary care's workforce problem
- How 7 systems divert behavioral health patients from the ED
- WellSpan Health, Hippocratic AI ink ‘multi-year’ partnership with plans to co-develop clinical AI agents
- Kaiser faces complaint over automated behavioral health triage system
- Free research hub Nila aims to demystify menopause, other hormone conditions
- Scientists Defend Fauci's Pandemic Work As Senate Hearing Turns Bitter
- Pfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie
- Study Questions Effectiveness of Antihistamines in Easing Eczema
- Vaping Is Likely Reshaping The Future Of Cancer In The US, Study Argues
- Weekly Rundown: Counsel Health rolls out white label AI care platform; Community Health Network launches MyChart AI assistant
- New CEO Garijo sketches out vision to reverse Sanofi's fortunes as Q2 delivers impressive sales beat
- Alnylam shares tank 29% as Amvuttra disappoints with ATTR outlook cut for 2026
- Waystar boosts 2026 outlook as AI-powered RCM solutions gain traction with providers
- YouTuber MrBeast welcomes Amgen to the channel, kicking off pediatric cancer funding effort
- Booming Dupixent sales fuel Regeneron's biggest quarter since pandemic
- Sugar Consumption Early In Life Linked To Increased Dementia Risk, World War II-Era Data Show
- Work Stress Harming Middle-Age Sleep, Study Says
- RFK Jr.'s Gardasil litigation ties subject to fresh lawmaker scrutiny after Merck settlement
- Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat
- Hospice's Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Cell Phone Ownership Linked To Lower Reading Skills In Elementary Students
- Listen to the Latest ‘KFF Health News Minute’
- Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients
- Medicaid Insurers’ Contracts on the Line in Tight Governor’s Race
- Teladoc Health trims 2026 revenue forecast amid challenges with BetterHelp insurance shift
- Cigna CEO: Express Scripts seeing 'significant early interest' from clients for new rebate-free PBM model
- Viatris runs into FDA roadblock after advertising on-the-go use of cystic fibrosis inhaler
- Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
- FTC sues Hims & Hers over data privacy, billing practices
- CMS' proposed 340B reimbursement cut—who wins, and who loses?
- Virtual care helps patients improve their gambling disorder symptoms, Birches Health finds
- Case Western Reserve University launches next-generation healthcare leadership program
- Lilly, Resilience commit $750M to boost US diabetes, obesity med production
- CMS ending Medicare Part D subsidy program
- Red Cross Declares Rare National Blood Supply Crisis Amid Summer Shortfall
- Not Just Pregnancy Fatigue: Could It Be Sleep Apnea?
- More Women Drinking During Pregnancy
- Wellstar Health System lays off 761 corporate, administrative staff
- Biogen flips '26 guidance from expected decline to sales increase
- Teva’s innovation engine offsets generics slump, leaving one analyst ‘shocked’ by Ajovy’s surge
- Talking To Your Baby? Eye Contact Is Key To Language Development, Experiment Shows
- Boosted by CMS settlement, Incyte expects Opzelura to cross $1B in 2026
- Leapfrog launches expanded ASC public reporting program
- Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead
- DoorDash, GrubHub Delivering Junk Food To 1 In 4 Teens During School Hours
- Uninsured but Undaunted, a Surgical Patient Searched the Globe for a Deal
- Trump Has Quietly Throttled an Agency Devoted to the Safety of American Healthcare
- Hospice’s Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Humana plans more market exits for 2027, CFO says
- PMCPA sanctions melatonin drugmaker over misleading information
- CG Life embraces next-gen era in merger with AI-native agency The Considered+AI
- How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval
- Fifth Death Reported In NYC Legionnaires' Disease Outbreak
- Many Young Adults Aren't Ready To Manage Their Own Healthcare, Poll Finds
- Can A Daily Multivitamin Help You Stay Active As You Age?
- Stellarus launches AI-powered health plan customer service representative copilot
- Prebiotic Soda Health Claims Questioned In New Nutrition Study
- Family-Based Childhood Obesity Program Helps Kids Cut Weight, Become Healthier
- To Afford Aging In Place, Older Adults Turn To 'Golden Girls' Housing
- Breakfast Can Help Teens Make Better Food Choices Throughout Their Day, Study Says
- Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California
- FDA Panel Backs Two Peptides For Compounding, Rejects One
- How Accurate Are Photo-Based Calorie Apps? 4 Are Put To The Test
- Popular School Cafeteria Meals Need An Update To Meet Healthy Food Standards, Researchers Say
- Ovarian Syndrome Quadruples Heart Disease Risk In Women, Major Study Concludes
- Weed-Killing Chemical, Glyphosate, Linked To Premature Births In Humans, Study Says
- 'The Child Is Terrified': Doctors On Front Lines Of Measles Comeback Speak Out
- 'Yo-yo' Weight Loss Linked To Decline In Muscle Mass
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Senate HELP committee advances nominees for CDC director, HHS preparedness head
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
Michigan healthcare freedom community forum
President Trump signed an executive order yesterday directing the federal government to promote addiction recovery:
ADDRESSING ADDICTION THROUGH THE GREAT AMERICAN RECOVERY INITIATIVE
Executive Orders
January 29, 2026By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered:
Section 1. Purpose and Policy. The disease of addiction, also known as substance use disorder, is a crisis that touches families in every community and neighborhood in our Nation. 48.4 million Americans, or 16.8 percent of our Nation’s population, suffer from addiction, and my Administration will continue to respond to a crisis of this scale with the attention it deserves. Over the past year, we have made incredible progress in stopping the inflow of illegal drugs that threaten American communities. We must now supplement that work by furthering a national effort to prioritize addiction treatment and recovery.
Addiction is a chronic, treatable disease with relapse rates similar to other chronic diseases. Unfortunately, very few Americans who need treatment ever receive it or believe they need it. Among the 40.7 million adults who had a substance use disorder in 2024 and did not receive substance use treatment, 95.6 percent (or 38.1 million people) did not perceive that they needed treatment. Despite significant investment of resources, addiction recovery efforts remain fragmented and do not keep pace with scientific advancements.
The costs of these failures are devastating, not only in lives lost, but also in the ripple effects across our economy, workforce, and national strength. Addiction contributes to declining workforce participation, increased healthcare costs, homelessness, family instability, and lost productivity that together cost the United States hundreds of billions of dollars each year.
The framework for addiction treatment should parallel that of other chronic diseases — utilizing evidence-based care, scientific advancement, continuous support, and community connection. My Administration will drive a new national response to the disease of addiction that will create stronger coordination across government, the healthcare sector, faith communities, and the private sector in order to save lives, restore families, strengthen our communities, and build the Great American Recovery.
Section 2. Launching the Great American Recovery Initiative. (a) There is hereby established the White House Great American Recovery Initiative (Initiative) co-chaired by the Secretary of Health and Human Services and the Senior Advisor for Addiction Recovery. There shall be an Executive Director who shall administer and execute the day to day operations of the Initiative, and who shall report to the Assistant to the President for Domestic Policy.
(b) In addition to the Co-Chairs and the Executive Director, the Initiative shall consist of the following officials, or their designees:
(i) the Attorney General;
(ii) the Secretary of the Interior;
(iii) the Secretary of Education;
(iv) the Secretary of Labor;
(v) the Secretary of Housing and Urban Development;
(vi) the Secretary of Veterans Affairs;
(vii) the Assistant to the President and Chief of Staff;
(viii) the Assistant to the President and Special Envoy for Peace Missions;
(ix) the Assistant to the President and Cabinet Secretary;
(x) the Director of National Drug Control Policy;
(xi) the Administrator of the Centers for Medicare and Medicaid Services;
(xii) the Commissioner of Food and Drugs;
(xiii) the Director of the National Institutes of Health;
(xiv) the Assistant Secretary for Mental Health and Substance Use, Department of Health and Human Services; and
(xv) the heads of such other executive departments, agencies, and offices that the Co-Chairs and the Executive Director may from time to time designate or invite to participate.
(c) The Co-Chairs may hold public hearings, meetings, roundtables, and similar events, as appropriate, and may receive expert input from leaders in public health, addiction and recovery treatment, and other relevant subject matter areas.
Section 3. Addressing the Disease of Addiction. The Co-Chairs and the Executive Director, along with the other members of the Initiative, shall:
(i) recommend all necessary steps to coordinate the Federal Government’s response to the addiction crisis, including by better aligning relevant Federal programs, setting clear objectives, and providing data-driven updates to the public on progress towards meeting these objectives;
(ii) take appropriate actions to increase awareness of the disease of addiction, help Americans receive the treatment they need, and foster a culture that celebrates recovery;
(iii) advise heads of executive departments and agencies (agency heads) on how to implement programs that integrate prevention, early intervention, treatment, recovery support, and re-entry into all relevant public health, healthcare, criminal justice, workforce, education, housing and social services systems, and remove outdated silos between agencies, programs, or systems, in each case as deemed appropriate by the agency head and consistent with applicable law;
(iv) advise agency heads on directing appropriate grants to support addiction recovery, with a focus on prevention, treatment, and long-term resilience; and
(v) consult with States, tribal nations, local jurisdictions, community-based organizations, faith‑based organizations, the private sector, and philanthropic entities on the best strategies to ensure more Americans receive the treatment they need and celebrate individuals going through the recovery process.
Section 4. General Provisions. (a) Nothing in this order shall be construed to impair or otherwise affect:
(i) the authority granted by law to an executive department or agency, or the head thereof; or
(ii) the functions of the Director of the Office of Management and Budget relating to budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with applicable law and subject to the availability of appropriations.
(c) This order is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person.
(d) The costs for publication of this order shall be borne by the Department of Health and Human Services.
DONALD J. TRUMP
THE WHITE HOUSE,
January 29, 2026.
The White House Fact Sheet:
Fact Sheet: President Donald J. Trump Launches the Great American Recovery Initiative to Address the Addiction Crisis
The White House
January 29, 2026LAUNCHING THE GREAT AMERICAN RECOVERY INITIATIVE: Today, President Donald J. Trump signed an Executive Order creating the White House Great American Recovery Initiative to coordinate a national response to the disease of addiction across government, healthcare, faith communities, and the private sector in order to save lives, restore families, strengthen our communities, and build the Great American Recovery.
The Order establishes the Initiative, co-chaired by the Secretary of Health and Human Services and the Senior Advisor for Addiction Recovery.
- Additional members of the Initiative include an executive director, cabinet secretaries, and senior administration leaders, some with deeply personal ties to the addiction crisis who are committed to ensuring Americans get the help they need.
The Order directs the Initiative to:
- Recommend all necessary steps to coordinate the Federal Government’s response to the addiction crisis, including by better aligning relevant Federal programs, setting clear objectives, and providing data-driven updates to the public on progress towards meeting these objectives;
- Take appropriate actions to increase awareness of the disease of addiction, help Americans receive the treatment they need, and foster a culture that celebrates recovery;
- Advise agencies on how to implement programs that integrate prevention, early intervention, treatment, recovery support, and re-entry;
- Advise agencies on directing appropriate grants to support addiction recovery, with a focus on prevention, treatment, and long-term resilience; and
- Consult with States, tribal nations, local jurisdictions, community-based organizations, faith-based organizations, the private sector, and philanthropic entities on the best strategies to ensure more Americans receive the treatment they need and celebrate individuals going through the recovery process.
MAKING PROGRESS ON THE DISEASE OF ADDICTION: The disease of addiction, also known as substance use disorder, is a crisis that touches families in every community in our Nation.
- Addiction is a chronic, treatable disease with relapse rates similar to other chronic diseases.
- 48.4 million Americans, or 16.8% of our Nation’s population, suffer from addiction, yet very few who need treatment receive it or believe they need it.
- Among the 40.7 million adults with a substance use disorder in 2024 who did not receive treatment, 95.6% (or 38.1 million people) did not perceive they needed it.
- Addiction contributes to declining workforce participation, increased healthcare costs, homelessness, family instability, and lost productivity that together cost the United States hundreds of billions of dollars each year.
- The framework for addiction treatment should parallel that of other chronic diseases – utilizing evidence-based care, scientific advancement, continuous support, and community connection.
DELIVERING ON PROMISES TO ADDRESS THE ADDICTION CRISIS: President Trump is committed to ending the addiction crisis and ensuring every American can access the help they need.
- He signed the SUPPORT Patients and Communities Reauthorization Act of 2025, strengthening Federal programs that address substance use disorders, overdoses, and mental health.
- He has taken aggressive action to stop the flow of deadly drugs into the United States, determined to save lives from the devastation caused by illicit narcotics crossing the border.
- He signed into law the HALT Fentanyl Act to permanently place Fentanyl-related substances into Schedule I of the Controlled Substances Act.
- His Administration is working to prevent drug use before it starts, strengthen treatment that leads to long-term recovery, and advance research and data to support effective drug control strategies.
- These efforts build on historic actions from President Trump’s first term, when he:
- Declared the opioid crisis a nationwide public health emergency.
- Signed the SUPPORT for Patients and Communities Act, the largest-ever legislative effort to address a drug crisis in our Nation’s history.
- Launched the Initiative to Stop Opioid Abuse and Reduce Drug Supply and Demand in order to confront the many causes fueling the drug crisis.
- Signed the CRIB Act, allowing Medicaid to help mothers and their babies who are born physically dependent on opioids by covering their care in residential pediatric recovery facilities.
- Distributed $1 billion in grants for addiction prevention and treatment.
- Announced a Safer Prescriber Plan to decrease the number of opioid prescriptions filled.
- Expanded access to medication-assisted treatment and life-saving Naloxone.
- Launched FindTreatment.gov, a tool to find help for substance abuse.
- Approved 29 state Medicaid demonstrations to improve access to opioid use disorder treatment, including new flexibility to cover inpatient and residential treatment.
The $ 100 million HHS pilot program:
Secretary Kennedy Announces $100 Million Investment in Great American Recovery
FOR IMMEDIATE RELEASE February 2, 2026
HHS Press Office
202-690-6343OXON HILL, MARYLAND — FEBRUARY 2, 2026 — Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. today announced a comprehensive plan to strengthen prevention, expand treatment, and carry out the executive order President Trump signed last week to ignite the Great American Recovery. The centerpiece of this plan is a $100 million investment to solve long-standing homelessness issues, fight opioid addiction, and improve public safety by expanding treatment that emphasizes recovery and self-sufficiency.
The Safety Through Recovery, Engagement, and Evidence-based Treatment and Supports — or STREETS — Initiative will fund targeted outreach, psychiatric care, medical stabilization and crisis intervention, while connecting Americans experiencing homelessness and addiction to stable housing with a clear focus on long-term recovery and independence.
“Addiction begins in isolation and ends in reconnection,” said Secretary Kennedy, who is co-chair of President Trump’s Great American Recovery Initiative. “Thanks to the leadership of President Trump, we are bringing Americans suffering from addiction out of the shadows and back into community.
”Secretary Kennedy made the announcement at Prevention Day, the largest government-sponsored gathering dedicated to advancing the prevention of substance use, hosted by the Substance Abuse and Mental Health Services Administration (SAMHSA), a division of HHS.
The $100 million investment directed by Secretary Kennedy is a clear departure from Biden-era policies that were misguided, failing to stem the tide of death, addiction, homelessness, and crime in American communities. These policies focused not on preventing and treating individuals, but rather non-effective interventions such as harm reduction, supporting housing first, and other strategies that enabled future drug use — and were never intended to support people in their recovery to lead productive lives in their communities.
Substance use disorder — impairment caused by repeated use of alcohol or other drugs — among people ages 12 and older rose from 7.4% in 2019 to 16.8% in 2024, according to SAMHSA survey data. Nearly 8 in 10 people with a substance use disorder in 2024 did not receive treatment.
Secretary Kennedy also announced the $10 million Assisted Outpatient Treatment (AOT) grant program to support adults with serious mental illness. AOT is a civil court-ordered, community-based outpatient mental health treatment program for adults with serious mental illness who are unable to engage with conventional outpatient treatment and are unlikely to be able to live safely in their community. The program is designed to work within the civil court system that supports engagement with community-based treatment as an alternative to more costly restrictive levels of care, homelessness, and interactions with the criminal justice system.
President Trump’s Executive Order Ending Crime and Disorder on America’s Streets on July 24, 2025 directed SAMHSA grants toward evidence-based substance use disorder programs with proven results and assisted outpatient treatment that moves people with serious mental illness or addiction off the streets and into stable housing and support networks. SAMHSA in September 2025 awarded more than $45 million in new supplemental funding to State Opioid Response program recipients to focus on sober or recovery housing among young adults.
The STREETS Initiative and AOT grant announcements coincide with SAMHSA’s $794 million first allocation of 2026 annual block grant awards, with $319 million going to support comprehensive community mental health services for adults with serious mental illness and children with serious emotional disturbance, and $475 million to the agency’s Substance Use Prevention, Treatment, and Recovery Services Block Grant program to prevent and treat substance abuse.
To help prevent family breakdown from substance use disorder, HHS’ Administration for Children and Families today under Secretary Kennedy’s plan added three Medications for Opioid Use Disorder (MOUD) as prevention services eligible for federal funding. States and tribes can now receive a 50% federal match, respectively, to provide buprenorphine, methadone, and naltrexone to parents when children are at imminent risk of entering foster care but can remain safely in the home or in a kinship placement with access to these treatments.
All three MOUD are U.S. Food and Drug Administration-approved, well-established, evidence-based tools that support recovery, promote family stability, and reduce risk factors associated with child welfare involvement.
SAMHSA and ACF intend to issue a Dear Colleague letter to emphasize that both agencies welcome full participation from faith-based organizations in their programs and activities.
President Trump declared upon establishing the White House Faith Office on February 7, 2025, “The executive branch wants faith-based entities, community organizations, and houses of worship, to the fullest extent permitted by law, to compete on a level playing field for grants, contracts, programs, and other Federal funding opportunities.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























